药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sibutramine
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lofexidine.
Sibutramine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Lofexidine.
Sibutramine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Lofexidine.
Sibutramine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Lofexidine.
Sibutramine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Lofexidine.
Sibutramine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Lofexidine.
Sibutramine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lofexidine.
Sibutramine
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Lofexidine.
Sibutramine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Lofexidine.
Sibutramine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Lofexidine.
Sibutramine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Lofexidine.
Sibutramine
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lofexidine.
Sibutramine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Lofexidine.
Sibutramine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Lofexidine.
Sibutramine
Dabrafenib
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lofexidine.
Sibutramine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Lofexidine.
Sibutramine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Lofexidine.
Sibutramine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Lofexidine.
Sibutramine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Lofexidine.
Sibutramine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lofexidine.